[{"id":"50c58012-9b92-4096-929a-64264a8757b1","acronym":"","url":"https://clinicaltrials.gov/study/NCT04761614","created_at":"2024-05-16T20:32:16.261Z","updated_at":"2024-07-02T16:35:03.341Z","phase":"Phase 1","brief_title":"Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer","source_id_and_acronym":"NCT04761614","lead_sponsor":"Ning Jin","biomarkers":" IFNG • IL6 • CRP • FCGRT • LIF","pipe":"","alterations":" ","tags":["IFNG • IL6 • CRP • FCGRT • LIF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • oxaliplatin • leucovorin calcium • fluorouracil topical • riluzole"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 13","initiation":"Initiation: 04/02/2021","start_date":" 04/02/2021","primary_txt":" Primary completion: 05/06/2023","primary_completion_date":" 05/06/2023","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2024-05-16"},{"id":"637f0fdb-1e17-4e99-915a-9893e88adafd","acronym":"","url":"https://clinicaltrials.gov/study/NCT04159649","created_at":"2023-09-27T08:10:09.144Z","updated_at":"2024-07-02T16:36:52.449Z","phase":"Phase 4","brief_title":"The Outcomes of ICSI Cycles With and Without Letrozole","source_id_and_acronym":"NCT04159649","lead_sponsor":"Mansoura University","biomarkers":" LIF","pipe":"","alterations":" ","tags":["LIF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e letrozole"],"overall_status":"Unknown status","enrollment":" Enrollment 224","initiation":"Initiation: 12/01/2019","start_date":" 12/01/2019","primary_txt":" Primary completion: 12/30/2020","primary_completion_date":" 12/30/2020","study_txt":" Completion: 12/30/2020","study_completion_date":" 12/30/2020","last_update_posted":"2019-12-16"}]